Association of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) with Cardiac Arrhythmias: A Systematic Review and Meta-Analysis of Cardiovascular Outcome Trials

Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) are a class of widely used hypoglycemic agents for the treatment of type 2 diabetes mellitus (T2DM). In addition to lowering blood glucose, SGLT2i protects the heart and kidney, significantly reduces cardiovascular events, and delays the...

Full description

Bibliographic Details
Main Authors: Xujie Wang, Xuexue Zhang, Wantong Zhang, Jiaxi Li, Weiliang Weng, Qiuyan Li
Format: Article
Language:English
Published: IMR Press 2023-09-01
Series:Reviews in Cardiovascular Medicine
Subjects:
Online Access:https://www.imrpress.com/journal/RCM/24/9/10.31083/j.rcm2409258